NRC Health Q2 FY26 GAAP net loss widens to $3.3 million; revenue rises 4% to $35.4 million

• NRC Health posted a GAAP net loss of $3.3 million, or $0.15 per diluted share, on revenue up 4% to $35.4 million.
• Total recurring contract value climbed 11% year-over-year to $151.9 million, signaling stronger contracted demand entering the second half.
• Adjusted EBITDA rose to $9.4 million, representing 27% of revenue; adjusted net income was $6.9 million, or $0.31 per diluted share.
• Operating cash flow totaled $1.4 million, while free cash flow was $0.1 million, reflecting about $2.9 million in cash payments tied to adjustment items.
• CEO Trent Green said results included double-digit TRCV growth, continued product commercialization, and the strongest Governance Institute bookings in seven years.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NRC Health published the original content used to generate this news brief via Business Wire (Ref. ID: 202607281600BIZWIRE_USPR_____20260728_BW285351) on July 28, 2026, and is solely responsible for the information contained therein.